Chromium XO and accessories for the USDA, ARS, Virus and Prior Research Unit in Ames, IA
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The USDA, ARS, Virus and Prior Research Unit in Ames, IA is seeking quotations for a Chromium XO single cell partitioning instrument and sequencing library prep kits. This is a Combined Synopsis/Solicitation (RFQ) for commercial items. The acquisition is an unrestricted requirement, with a strong indication of a sole-source award to 10X Genomics, Inc. due to a "Decision to Restrict Competition." Quotations are due by April 10, 2026.
Scope of Work
The requirement is for a 10X Genomics Chromium X or equivalent instrument capable of partitioning hundreds of thousands of cells, capturing molecular readouts, and being upgradeable for various research applications. It must handle 8 samples in parallel and be compatible with GEM-X microfluidic chips. The instrument must include a 12-month warranty.
Associated reagents and kits include:
- Chromium XO & Accessory kit (1 EA)
- Dual Index Kit TT Set A, 96 reactions (1 EA)
- GEM-X OCM 3’ Chip Kit v4 4-plex, 2 chips (2 EA)
- GEM-X Universal 3’ Gene Expression v4 4-plex, 16 samples (2 EA)
Delivery is required within 60 days after receipt of order to USDA, 1920 Dayton Avenue, Bldg 24, Ames, IA 50010.
Contract & Timeline
- Type: Request for Quotation (RFQ), anticipated Firm-Fixed Price contract.
- Set-Aside: Unrestricted requirement, with a "Decision to Restrict Competition" indicating a likely sole-source award to 10X Genomics, Inc.
- Questions Due: April 7, 2026
- Quotations Due: April 10, 2026, 7:00 PM Z
- Published: April 3, 2026
- Place of Performance: Ames, IA
Evaluation
Award will be made to the offeror representing the best value to the Government, based on:
- Technical Approach: Ability to meet schedule, thorough understanding of requirements, and capability.
- Price: Must be fair and reasonable.
- Past Performance: Evaluated as Acceptable, Neutral, or Unacceptable.
Quotations will be evaluated for technical advantage first. The highest technically rated offeror's price and past performance will then be assessed. Award will not necessarily be made to the lowest-priced offeror, and tradeoffs will not be conducted.
Additional Notes
Offerors must be registered in SAM.gov. The justification for restricting competition highlights that 10X Genomics is the sole manufacturer and seller of the ChromiumXO instrument, and market research did not identify other interested sources.